EN4-10283-55629
5 vaccinations
10 coded responses
43 check-ins
10 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 009 / PR
- Registered
- 2020-12-24
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-16
Dose 1 — Pfizer-BioNTech
-
2020-12-24
Registered in v-safe
- 2020-12-24
- 2020-12-30
-
2021-01-05
Dose 2 — Pfizer-BioNTech
- 2021-01-05
-
2021-01-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body achesAdult check-in
-
2021-01-07
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Axillary lymphadenopathy (same side of vaccine injection)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-08
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Milder axillary lymphadenopathy (same arm of injection)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-09
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Smaller, mild, painless axillary lymphadenopathy (same side of injection)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-14
Survey response — day 7, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Improved axillary lymphadenopathy (same side of vaccination)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-19
- 2021-01-26
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-04-06
- 2021-07-06
-
2021-09-05
Dose 3 — Pfizer-BioNTech
- 2021-09-28
- 2021-10-03
- 2021-10-10
- 2021-10-17
- 2021-12-05
- 2022-03-06
-
2022-04-08
Dose 4 — Pfizer-BioNTech
-
2022-04-15
Survey response — day 7, dose 4MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Redness, Swelling · Joint painsFree text: Axillary lymphadenopathy in the same side of the shotMedDRA releases: 2024-11 · check-in free text available
- 2022-04-22
- 2022-04-29
- 2022-05-06
- 2022-05-15
- 2022-05-22
- 2022-07-08
- 2022-10-08
-
2022-10-21
Dose 5 — Pfizer-BioNTech
-
2022-10-22
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2022-10-23
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2022-10-24
Survey response — days 1–6 daily, dose 5MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Axillary lymphadenopathy on the same arm of injectionMedDRA releases: 2024-11 · check-in free text available
-
2022-10-25
Survey response — days 1–6 daily, dose 5MedDRA: Lymphadenopathy — Feeling: GoodFree text: Axillary lymphadenopathy on the same side of vaccine injectionMedDRA releases: 2024-11 · check-in free text available
-
2022-10-26
Survey response — days 1–6 daily, dose 5MedDRA: Lymphadenopathy — Feeling: GoodFree text: Axillary lymphadenopathy on the same side of vaccine injectionMedDRA releases: 2024-11 · check-in free text available
-
2022-10-27
Survey response — days 1–6 daily, dose 5MedDRA: Lymphadenopathy — Feeling: GoodFree text: Axillary lymphadenopathy on the same side of vaccine injection, less noticeableMedDRA releases: 2024-11 · check-in free text available
-
2022-10-28
Survey response — day 7, dose 5MedDRA: Lymphadenopathy — Feeling: GoodFree text: Axillary lymphadenopathy on the same side of vaccine injection, less noticeableMedDRA releases: 2024-11 · check-in free text available
- 2022-11-04
- 2022-11-11
- 2022-11-18
- 2022-11-25
- 2022-12-02
- 2023-01-20
- 2023-04-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | |
| 2 | 2021-01-05 | Pfizer-BioNTech | |
| 3 | 2021-09-05 | Pfizer-BioNTech | No |
| 4 | 2022-04-08 | Pfizer-BioNTech | No |
| 5 | 2022-10-21 | Pfizer-BioNTech | No |
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Axillary lymphadenopathy (same side of vaccine injection)
Systemic reaction (other): Milder axillary lymphadenopathy (same arm of injection)
Systemic reaction (other): Smaller, mild, painless axillary lymphadenopathy (same side of injection)
Release 2 — day 7, dose 2
Systemic reaction (other): Improved axillary lymphadenopathy (same side of vaccination)
Release 11 — day 7, dose 4
Systemic reaction (other): Axillary lymphadenopathy in the same side of the shot
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): Axillary lymphadenopathy on the same arm of injection
Systemic reaction (other): Axillary lymphadenopathy on the same side of vaccine injection
Systemic reaction (other): Axillary lymphadenopathy on the same side of vaccine injection
Systemic reaction (other): Axillary lymphadenopathy on the same side of vaccine injection, less noticeable
Release 12 — day 7, dose 5
Systemic reaction (other): Axillary lymphadenopathy on the same side of vaccine injection, less noticeable
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release